Market Cap 140.89B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.20
Forward PE 8.40
Profit Margin 12.42%
Debt to Equity Ratio 0.71
Volume 76,962,600
Avg Vol 38,514,320
Day's Range N/A - N/A
Shares Out 5.70B
Stochastic %K 4%
Beta 0.34
Analysts Sell
Price Target $29.28

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
Wealthy500
Wealthy500 Jun. 25 at 4:58 AM
0 · Reply
StocktwitsNews
StocktwitsNews Jun. 25 at 4:14 AM
VKTX Stock Eyes Best Week In 2 Years: Retail Bulls Bet Q3 Obesity Data Could Put Novo, Big Pharma In Buyout Play $VKTX $NVO $PFE $LLY https://stocktwits.com/news/equity/markets/vktx-bulls-q3-obesity-data-novo-big-pharma-buyout/cZ1G5RqR7QQ
1 · Reply
sam92
sam92 Jun. 25 at 3:29 AM
$PFE Should start heading higher now Pfizer Dismissed from Antitrust Lawsuit, Reducing Legal Exposure Written by Emily J. Thompson, Senior Investment Analyst https://intellectia.ai/news/monitor/pfizer-dismissed-from-antitrust-lawsuit-reducing-legal-exposure
0 · Reply
umiak1
umiak1 Jun. 25 at 2:35 AM
$PFE “ PFE has been dismissed as a defendant in a lawsuit brought by 45 US states, the District of Columbia, and 4 US territories that accused drugmakers and executives of fixing generic drug prices, Reuters reported Wednesday, citing a court decision. Chief Judge of the federal district court in Connecticut, said in a Tuesday ruling the states failed to establish that Pfizer and its former Greenstone unit colluded with competitors to rig bids and allocate customers for drug products, according to the report. Pfizer is pleased with the Court's decision to grant summary judgment and dismiss all claims against Pfizer- which had no involvement in the alleged conduct and should never have been named in the complaint to begin with", a Pfizer spokesperson said in an emailed statement to MT Newswires.”
0 · Reply
Zero12345
Zero12345 Jun. 25 at 12:45 AM
$PFE People on this board are too pessimistic right now... AI Bob & Mike posted today on Yahoo Finance: "One thing the Al trading computers know is they are running out of time to get into PFE. PFE has beaten earnings for the last 4Q in a row and that Q 1 showed real growth as new products are doing better than was forecasted and that the $7 billion in cost cuts put the floor in the earnings with only upside. Only a matter of time before the Al trading computers start attacking the over priced tech stocks because that is were the real money to be made is." "There are four core golden eggs (FDA-approved therapies) that Seagen fully commercialized and brought to Pfizer at the time of the acquisition. Pfizer was not buying the golden eggs. We are acquiring the goose that is laying the golden eggs. So one egg is a little scrambled, but it's still gonna produce."
0 · Reply
BillionerOfKing
BillionerOfKing Jun. 25 at 12:41 AM
$PFE Current Stock Price: $24.05 Contracts to trade: $24.0 PFE Jun 26 2026 Call Entry: $0.24 Exit: $0.41 ROI: 70% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Micheal_Pothead
Micheal_Pothead Jun. 25 at 12:10 AM
$PFE you would have had to buy this stock 22 years ago to have out paced inflation and been positive on your investment
1 · Reply
Cedenmo
Cedenmo Jun. 25 at 12:07 AM
$PFE As a shareholder of this and $TGTX, i say write the check for $20B (I’d prefer more PFE shares though as I love the price and yield here). TGTX has a sure winner in Briumvi which can easily do $5-10B in big hands. Expanding franchise to SubQ and a platform to other indications. Then Azer cel as well. Would love to stay vested in Briumvi’s success here post-TGTX.
1 · Reply
MR2601
MR2601 Jun. 25 at 12:03 AM
$PFE top management is full of bureaucratic attitude not business man like approach ; their Seagen acquisition was a mess as they paid so high for it. Rather they could pick up some small outfits like NUBV , CADL,URGN and get better leverage . These top guys are full of themselves and as a result the SP is suffering just from a Phase 3 bad data and uncertainty .
0 · Reply
Micheal_Pothead
Micheal_Pothead Jun. 24 at 11:58 PM
$PFE what if we paid the LLY CEO like 200m a year to swap over
0 · Reply
Latest News on PFE
Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 3:52 PM EDT - 10 hours ago

Pfizer Declares Third-Quarter 2026 Dividend


Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 24, 2026, 10:51 AM EDT - 15 hours ago

Pfizer dismissed from US states' drug price-fixing lawsuit


Pfizer (PFE) Shares Sink After Surprise CFO Exit

2026-06-18T18:35:11.000Z - 6 days ago

Pfizer (PFE) Shares Sink After Surprise CFO Exit


Pfizer reaffirms all components of FY26 guidance

2026-06-18T17:30:31.000Z - 6 days ago

Pfizer reaffirms all components of FY26 guidance


Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:52 AM EDT - 6 days ago

Pfizer CFO Dave Denton to step down, leave company in August


Pfizer Announces Chief Financial Officer Transition

Jun 18, 2026, 6:45 AM EDT - 6 days ago

Pfizer Announces Chief Financial Officer Transition


Pfizer says FDA approves expanded indication for Hympavzi

2026-06-08T10:51:57.000Z - 16 days ago

Pfizer says FDA approves expanded indication for Hympavzi


US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:49 AM EDT - 16 days ago

US FDA approves Pfizer's bleeding disorder drug for children


Pfizer presents results from Phase 2b studies of berobenatide

2026-06-07T22:00:49.000Z - 17 days ago

Pfizer presents results from Phase 2b studies of berobenatide


Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 18 days ago

Pfizer Transcript: Study update


Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 18 days ago

Pfizer Slides: Study update


Mailbag: A Follow-Up on Pfizer & Other Questions

May 30, 2026, 9:22 AM EDT - 25 days ago

Mailbag: A Follow-Up on Pfizer & Other Questions

AGNC LAND NLY PFFA


Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

May 5, 2026, 4:09 PM EDT - 7 weeks ago

Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC


Pfizer CEO on AI-designed molecule, and race to use new tech

May 5, 2026, 4:02 PM EDT - 7 weeks ago

Pfizer CEO on AI-designed molecule, and race to use new tech


3 Dividend Stocks for May 2026

May 5, 2026, 11:30 AM EDT - 7 weeks ago

3 Dividend Stocks for May 2026

SYY WSO


Pfizer Earnings Call Transcript: Q1 2026

May 5, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Earnings Call Transcript: Q1 2026


Pfizer Earnings release: Q1 2026

May 5, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Earnings release: Q1 2026


Pfizer Quarterly report: Q1 2026

May 5, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Quarterly report: Q1 2026


Pfizer Slides: Q1 2026

May 5, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Slides: Q1 2026


Pfizer Posts Better-Than-Expected Revenue, Profit

May 5, 2026, 8:35 AM EDT - 7 weeks ago

Pfizer Posts Better-Than-Expected Revenue, Profit


Why selling these 3 dividend stocks could be a mistake

May 5, 2026, 7:05 AM EDT - 7 weeks ago

Why selling these 3 dividend stocks could be a mistake

EPD UPS


US FDA approves Pfizer, Arvinas' breast cancer drug

May 1, 2026, 12:37 PM EDT - 7 weeks ago

US FDA approves Pfizer, Arvinas' breast cancer drug

ARVN


Pfizer's blood cancer drug meets main goal in late-stage trial

Apr 29, 2026, 7:42 AM EDT - 2 months ago

Pfizer's blood cancer drug meets main goal in late-stage trial


Wealthy500
Wealthy500 Jun. 25 at 4:58 AM
0 · Reply
StocktwitsNews
StocktwitsNews Jun. 25 at 4:14 AM
VKTX Stock Eyes Best Week In 2 Years: Retail Bulls Bet Q3 Obesity Data Could Put Novo, Big Pharma In Buyout Play $VKTX $NVO $PFE $LLY https://stocktwits.com/news/equity/markets/vktx-bulls-q3-obesity-data-novo-big-pharma-buyout/cZ1G5RqR7QQ
1 · Reply
sam92
sam92 Jun. 25 at 3:29 AM
$PFE Should start heading higher now Pfizer Dismissed from Antitrust Lawsuit, Reducing Legal Exposure Written by Emily J. Thompson, Senior Investment Analyst https://intellectia.ai/news/monitor/pfizer-dismissed-from-antitrust-lawsuit-reducing-legal-exposure
0 · Reply
umiak1
umiak1 Jun. 25 at 2:35 AM
$PFE “ PFE has been dismissed as a defendant in a lawsuit brought by 45 US states, the District of Columbia, and 4 US territories that accused drugmakers and executives of fixing generic drug prices, Reuters reported Wednesday, citing a court decision. Chief Judge of the federal district court in Connecticut, said in a Tuesday ruling the states failed to establish that Pfizer and its former Greenstone unit colluded with competitors to rig bids and allocate customers for drug products, according to the report. Pfizer is pleased with the Court's decision to grant summary judgment and dismiss all claims against Pfizer- which had no involvement in the alleged conduct and should never have been named in the complaint to begin with", a Pfizer spokesperson said in an emailed statement to MT Newswires.”
0 · Reply
Zero12345
Zero12345 Jun. 25 at 12:45 AM
$PFE People on this board are too pessimistic right now... AI Bob & Mike posted today on Yahoo Finance: "One thing the Al trading computers know is they are running out of time to get into PFE. PFE has beaten earnings for the last 4Q in a row and that Q 1 showed real growth as new products are doing better than was forecasted and that the $7 billion in cost cuts put the floor in the earnings with only upside. Only a matter of time before the Al trading computers start attacking the over priced tech stocks because that is were the real money to be made is." "There are four core golden eggs (FDA-approved therapies) that Seagen fully commercialized and brought to Pfizer at the time of the acquisition. Pfizer was not buying the golden eggs. We are acquiring the goose that is laying the golden eggs. So one egg is a little scrambled, but it's still gonna produce."
0 · Reply
BillionerOfKing
BillionerOfKing Jun. 25 at 12:41 AM
$PFE Current Stock Price: $24.05 Contracts to trade: $24.0 PFE Jun 26 2026 Call Entry: $0.24 Exit: $0.41 ROI: 70% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Micheal_Pothead
Micheal_Pothead Jun. 25 at 12:10 AM
$PFE you would have had to buy this stock 22 years ago to have out paced inflation and been positive on your investment
1 · Reply
Cedenmo
Cedenmo Jun. 25 at 12:07 AM
$PFE As a shareholder of this and $TGTX, i say write the check for $20B (I’d prefer more PFE shares though as I love the price and yield here). TGTX has a sure winner in Briumvi which can easily do $5-10B in big hands. Expanding franchise to SubQ and a platform to other indications. Then Azer cel as well. Would love to stay vested in Briumvi’s success here post-TGTX.
1 · Reply
MR2601
MR2601 Jun. 25 at 12:03 AM
$PFE top management is full of bureaucratic attitude not business man like approach ; their Seagen acquisition was a mess as they paid so high for it. Rather they could pick up some small outfits like NUBV , CADL,URGN and get better leverage . These top guys are full of themselves and as a result the SP is suffering just from a Phase 3 bad data and uncertainty .
0 · Reply
Micheal_Pothead
Micheal_Pothead Jun. 24 at 11:58 PM
$PFE what if we paid the LLY CEO like 200m a year to swap over
0 · Reply
dewmoore
dewmoore Jun. 24 at 11:38 PM
$SLS Follow the data/the numbers don't lie! Every morning we have the DAILY pre-market shakeout! Mon: Pre-market low $8.19 ➜ bought up to close at $8.53 Tue: Pre-market dipped to $8.27 ➜ stair-stepped to close at $9.07 Wed: Pre-market dipped to $8.95 ➜ pushed over $9.15 near 52-week highs IBKR Availability: ZERO shares. Borrow Fee: Sitting at its absolute monthly peak of 149% (with Robinhood touching 261%+). The Close: Massive buy-side imbalances right into the bell (153k paired vs. 112k imbalance). They paint the tape red in thin early hours to get fools to sell, but when the bell rings the dip is quickly bought up LOL ! Shorts are trapped paying triple-digit premiums on a position they can’t even hedge or add to. It's a textbook pressure cooker. Hold the line, turn off share lending, and remove the stop losses. It’s a supply-demand mismatch ready to snap. 🚀 $WEN $PFE $LLY $MRK
1 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Jun. 24 at 10:20 PM
$PFE 💪🏻
1 · Reply
Typecheck
Typecheck Jun. 24 at 10:02 PM
$PFE The biggest problem with Al Bourla and his band of fools is that they believe spending 43 Billion dollars for a company so that they can make 5 billion dollars within 10 years is a good deal. All recent acquisitions are failure or colossal failure.
2 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Jun. 24 at 9:37 PM
$PFE *Insert smol violin 🎻*
0 · Reply
A_Train1
A_Train1 Jun. 24 at 9:14 PM
$PFE well, I guess we’ll have another dump in July? I never look forward to dividend day anymore. Isn’t that a shame?
2 · Reply
StocktwitsNews
StocktwitsNews Jun. 24 at 9:14 PM
PFE Stock Continues To Drop As Lung Cancer Trial Disappointment Overshadows Ibrance Win $PFE $VTI $VOO https://stocktwits.com/news/equity/markets/pfe-stock-continues-to-drop-as-lung-cancer-trial-disappointment-overshadows-ibrance-win/cZKyn58R7Qc
0 · Reply
Micheal_Pothead
Micheal_Pothead Jun. 24 at 8:56 PM
$PFE yay… Chip stocks are pumping again..
3 · Reply
A_Train1
A_Train1 Jun. 24 at 8:38 PM
$PFE this latest failure on the phase 3 has got to drive some change, no? I just cannot see them continuing down this path. It is clear that Wall Street does not like the current leadership, and every success is met with resistance while every failure is amplified
1 · Reply
sam92
sam92 Jun. 24 at 8:11 PM
$PFE Pfizer declares $0.43 dividend
0 · Reply
reyofhope
reyofhope Jun. 24 at 8:01 PM
$PFE I put 50 thousand in this nonsense last year I should have put it in amd and I would have been on a beach. We all screwed up here guys. Don't trust this Greek old fool. I'm so pissed right now and now I'm stuck here waiting for this idiot to turn this around.
3 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Jun. 24 at 7:57 PM
$PFE - Sad yay https://investors.pfizer.com/Investors/news-events/News/news-details/2026/Pfizer-Declares-Third-Quarter-2026-Dividend/default.aspx
1 · Reply
sam92
sam92 Jun. 24 at 7:55 PM
$PFE Pfizer granted FDA label expansion for breast cancer drug, Ibrance
1 · Reply